CL2019001292A1 - Nuevos derivados de quinolina. - Google Patents

Nuevos derivados de quinolina.

Info

Publication number
CL2019001292A1
CL2019001292A1 CL2019001292A CL2019001292A CL2019001292A1 CL 2019001292 A1 CL2019001292 A1 CL 2019001292A1 CL 2019001292 A CL2019001292 A CL 2019001292A CL 2019001292 A CL2019001292 A CL 2019001292A CL 2019001292 A1 CL2019001292 A1 CL 2019001292A1
Authority
CL
Chile
Prior art keywords
compounds
new quinoline
quinoline derivatives
preparation
pharmaceutical compositions
Prior art date
Application number
CL2019001292A
Other languages
English (en)
Spanish (es)
Inventor
Johannes Köbberling
Adeline Köhler
Thomas Ilg
Ulrich Görgens
Hans-Georg Schwarz
Claudia Welz
Kirsten Börngen
Daniel Kulke
Walter Hübsch
Maike Hink
Claudia Böhm
Niels Lindner
Wei Zhuang
Nils Griebenow
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of CL2019001292A1 publication Critical patent/CL2019001292A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53771,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
CL2019001292A 2016-11-11 2019-05-10 Nuevos derivados de quinolina. CL2019001292A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP16198550 2016-11-11

Publications (1)

Publication Number Publication Date
CL2019001292A1 true CL2019001292A1 (es) 2019-09-27

Family

ID=57321155

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2019001292A CL2019001292A1 (es) 2016-11-11 2019-05-10 Nuevos derivados de quinolina.

Country Status (26)

Country Link
US (2) US10889573B2 (https=)
EP (1) EP3538512B1 (https=)
JP (1) JP7165129B2 (https=)
KR (1) KR102595730B1 (https=)
CN (1) CN109890793B (https=)
AU (1) AU2017357503B2 (https=)
CA (1) CA3043298A1 (https=)
CL (1) CL2019001292A1 (https=)
CO (1) CO2019004776A2 (https=)
DK (1) DK3538512T3 (https=)
DO (1) DOP2019000117A (https=)
ES (1) ES2884073T3 (https=)
IL (1) IL266407B (https=)
MX (1) MX2019005569A (https=)
MY (1) MY196327A (https=)
NZ (1) NZ752550A (https=)
PH (1) PH12019501034A1 (https=)
PL (1) PL3538512T3 (https=)
PT (1) PT3538512T (https=)
SG (1) SG11201903059SA (https=)
SI (1) SI3538512T1 (https=)
TW (1) TWI821165B (https=)
UA (1) UA126119C2 (https=)
UY (1) UY37480A (https=)
WO (1) WO2018087036A1 (https=)
ZA (1) ZA201903708B (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12312356B2 (en) 2020-05-29 2025-05-27 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic heterocyclic compounds
US12435068B2 (en) 2018-10-24 2025-10-07 Elanco Animal Health Gmbh Anthelmintic compounds

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11485733B2 (en) 2017-06-30 2022-11-01 Bayer Animal Health Gmbh Azaquinoline derivatives
SG11202000266VA (en) * 2017-08-04 2020-02-27 Bayer Animal Health Gmbh Quinoline derivatives for treating infections with helminths
KR20200099548A (ko) * 2017-12-15 2020-08-24 바이엘 애니멀 헬스 게엠베하 구충제 4-아미노-퀴놀린-3-카르복스아미드 유도체를 제조하는 방법
JP7403472B2 (ja) * 2018-05-09 2023-12-22 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 新規キノリン誘導体
AU2019301510B2 (en) 2018-07-09 2024-06-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anthelminthic heterocyclic compounds
CN113490527B (zh) * 2018-12-18 2024-10-25 瑞士伊兰科动物保健有限公司 双环衍生物
NZ777370A (en) 2018-12-18 2024-11-29 Elanco Tiergesundheit Ag Bicyclic derivatives
CA3133100A1 (en) 2019-03-19 2020-09-24 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic aza-benzothiophene and aza-benzofuran compounds
BR112021024726A2 (pt) * 2019-06-07 2022-01-18 Elanco Tiergesundheit Ag Novos derivados bicíclicos
TWI865563B (zh) 2019-07-30 2024-12-11 德商拜耳動物保健有限公司 新穎異喹啉衍生物
EP4077322A1 (en) 2019-12-18 2022-10-26 Intervet International B.V. Anthelmintic compounds comprising azaindoles structure
AU2020406093A1 (en) * 2019-12-18 2022-06-16 Intervet International B.V. Anthelmintic compounds comprising a quinoline structure
JP2023521342A (ja) * 2020-04-09 2023-05-24 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 駆虫性化合物としての置換縮合アジン類
WO2022106469A2 (en) 2020-11-18 2022-05-27 Elanco Tiergesundheit Ag N-(2,3-dihydro-1,4-benzoxazin-4-yl)-3-isopropyl-7-(2,3,5-trifluorophenyl)benzo-thiophene-2-carboxamide derivatives and similar compounds for the treatment of heartworm infections
CN116685584A (zh) * 2020-11-18 2023-09-01 礼蓝动物保健有限公司 用于治疗心丝虫感染的n-(2,3-二氢-1,4-苯并噁嗪-4-基)-3-异丙基-7-(2,3,5-三氟苯基)苯并噻吩-2-甲酰胺衍生物和类似化合物
CN116888124A (zh) * 2020-12-04 2023-10-13 礼蓝动物保健有限公司 二环衍生物
TW202237600A (zh) 2020-12-04 2022-10-01 瑞士商禮藍動物保健股份有限公司 雙環衍生物
US20240043385A1 (en) 2020-12-11 2024-02-08 Intervet Inc. Anthelmintic compounds comprising a pyridine structure
US20240043446A1 (en) 2020-12-11 2024-02-08 Intervet Inc. Anthelmintic compounds comprising a thienopyridine structure
EP4148052A1 (en) 2021-09-09 2023-03-15 Bayer Animal Health GmbH New quinoline derivatives
UY39995A (es) 2021-11-01 2023-05-15 Boehringer Ingelheim Vetmedica GmbH Compuestos de pirrolopiridazina como antihelmínticos
WO2024213752A1 (en) 2023-04-14 2024-10-17 Elanco Animal Health Gmbh Long-term prevention and/or treatment of a disease by slo-1 inhibitors
IL326231A (en) 2023-08-02 2026-03-01 Intervet Int Bv Carboxamide-4-quinoline compounds with anthelmintic activity
WO2026078157A2 (en) 2024-10-10 2026-04-16 Elanco Animal Health Gmbh Slo-1 modulators for prevention and/or treatment of a disease

Family Cites Families (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343804A (en) * 1979-03-26 1982-08-10 A. H. Robins Company, Inc. 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds
KR840000768A (ko) * 1982-07-23 1984-02-27 박이은 무연통의 무연탄 난로
DE3639877A1 (de) 1986-11-21 1988-05-26 Bayer Ag Hetarylalkyl substituierte 5- und 6-ringheterocyclen
US6559145B2 (en) 2000-07-12 2003-05-06 Pharmacia & Upjohn Company Heterocycle carboxamides as antiviral agents
GB0213715D0 (en) 2002-06-14 2002-07-24 Syngenta Ltd Chemical compounds
TWI312272B (en) 2003-05-12 2009-07-21 Sumitomo Chemical Co Pyrimidine compound and pests controlling composition containing the same
GB0414438D0 (en) 2004-06-28 2004-07-28 Syngenta Participations Ag Chemical compounds
WO2006043635A1 (ja) 2004-10-20 2006-04-27 Kumiai Chemical Industry Co., Ltd. 3-トリアゾリルフェニルスルフィド誘導体及びそれを有効成分として含有する殺虫・殺ダニ・殺線虫剤
CA2603345C (en) * 2005-04-01 2017-05-02 Insa Rouen New heterocyclic compounds, their preparation and their use as medicaments, in particular as anti-alzheimer agents
US8338607B2 (en) 2005-10-06 2012-12-25 Nippon Soda Co., Ltd. Cyclic amine compounds and agents for pest control
JP2008214323A (ja) 2007-03-08 2008-09-18 Kyowa Hakko Kogyo Co Ltd 皮膚疾患の治療及び/または予防剤
WO2008154442A1 (en) 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
JP5268461B2 (ja) 2008-07-14 2013-08-21 Meiji Seikaファルマ株式会社 Pf1364物質、その製造方法、生産菌株、及び、それを有効成分とする農園芸用殺虫剤
CN101337937B (zh) 2008-08-12 2010-12-22 国家农药创制工程技术研究中心 具有杀虫活性的n-苯基-5-取代氨基吡唑类化合物
CN101337940B (zh) 2008-08-12 2012-05-02 国家农药创制工程技术研究中心 具杀虫活性的含氮杂环二氯烯丙醚类化合物
CN101715774A (zh) 2008-10-09 2010-06-02 浙江化工科技集团有限公司 一个具有杀虫活性化合物制备及用途
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
GB0820344D0 (en) 2008-11-06 2008-12-17 Syngenta Ltd Herbicidal compositions
AU2009324389B2 (en) 2008-12-12 2016-04-28 Syngenta Crop Protection Ag Spiroheterocyclic N-oxypiperidines as pesticides
WO2011036074A1 (en) * 2009-09-24 2011-03-31 Basf Se Aminoquinazoline compounds for combating invertebrate pests
WO2011085575A1 (zh) 2010-01-15 2011-07-21 江苏省农药研究所股份有限公司 邻杂环甲酰苯胺类化合物及其合成方法和应用
AR081721A1 (es) 2010-02-25 2012-10-17 Nippon Soda Co Compuesto de amina ciclica y acaricida
BR112012030408A2 (pt) 2010-05-31 2015-09-29 Syngenta Participations Ag método de melhoramento de culturas
AU2011297160B2 (en) 2010-08-31 2014-11-20 Mitsui Chemicals Crop & Life Solutions, Inc. Noxious organism control agent
CN101967139B (zh) 2010-09-14 2013-06-05 中化蓝天集团有限公司 一种含一氟甲氧基吡唑的邻甲酰氨基苯甲酰胺类化合物、其合成方法及应用
WO2012112363A1 (en) 2011-02-14 2012-08-23 Merck Sharp & Dohme Corp. Cathepsin cysteine protease inhibitors
WO2013050317A1 (en) 2011-10-03 2013-04-11 Syngenta Limited Polymorphs of an isoxazoline derivative
CN102391261A (zh) 2011-10-14 2012-03-28 上海交通大学 一种n-取代噁二嗪类化合物及其制备方法和应用
TW201326128A (zh) * 2011-11-28 2013-07-01 Du Pont 磺醯胺驅蟲劑
WO2013096151A1 (en) 2011-12-22 2013-06-27 Glaxosmithkline Llc Chemical compounds
TWI566701B (zh) 2012-02-01 2017-01-21 日本農藥股份有限公司 芳烷氧基嘧啶衍生物及包含該衍生物作為有效成分的農園藝用殺蟲劑及其使用方法
WO2013118071A1 (en) 2012-02-09 2013-08-15 Glenmark Pharmaceuticals S.A. BICYCLIC COMPOUNDS AS mPGES-1 INHIBITORS
EP2830421B1 (en) 2012-03-30 2017-03-01 Basf Se N-substituted pyridinylidene thiocarbonyl compounds and their use for combating animal pests
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
BR122014028247A2 (pt) 2012-04-27 2019-05-07 Dow Agrosciences Llc composições pesticidas, processo para controlar praga, uso de uma molécula, processo para aumentar a saúde, rendimento, vigor, qualidade ou tolerância de uma planta e processos para produção de compostos
US9282739B2 (en) 2012-04-27 2016-03-15 Dow Agrosciences Llc Pesticidal compositions and processes related thereto
JP2016508972A (ja) * 2012-12-20 2016-03-24 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 殺ダニ剤及び殺虫剤としてのアリールスルフィド誘導体及びアリールスルホキシド誘導体
CN103109816B (zh) 2013-01-25 2014-09-10 青岛科技大学 硫代苯甲酰胺类化合物及其应用
CN103232431B (zh) 2013-01-25 2014-11-05 青岛科技大学 一种二卤代吡唑酰胺类化合物及其应用
US20140275503A1 (en) 2013-03-13 2014-09-18 Dow Agrosciences Llc Process for the preparation of certain triaryl rhamnose carbamates
JP6595985B2 (ja) 2013-05-23 2019-10-23 シンジェンタ パーティシペーションズ アーゲー タンク混合配合物
CN103265527B (zh) 2013-06-07 2014-08-13 江苏省农用激素工程技术研究中心有限公司 邻氨基苯甲酰胺化合物及其制备方法和应用
CN103524422B (zh) 2013-10-11 2015-05-27 中国农业科学院植物保护研究所 苯并咪唑衍生物及其制备方法和用途
JP2016539092A (ja) 2013-10-17 2016-12-15 ダウ アグロサイエンシィズ エルエルシー 有害生物防除性化合物の製造方法
EP3057429A4 (en) 2013-10-17 2017-08-09 Dow AgroSciences LLC Processes for the preparation of pesticidal compounds
AR098475A1 (es) * 2013-11-26 2016-06-01 Bayer Cropscience Ag Compuestos pesticidas y usos
US9938292B2 (en) * 2014-03-24 2018-04-10 Guangdong Zhongsheng Pharmaceutical Co., Ltd Quinoline derivatives as SMO inhibitors
TW201613866A (en) 2014-07-07 2016-04-16 Bayer Cropscience Ag Process for preparing fluorinated iminopyridine compounds
CA2975982C (en) 2015-02-17 2018-11-27 Nippon Soda Co., Ltd. Agrochemical composition
CN108430992A (zh) 2015-12-17 2018-08-21 阿斯特克斯医疗公司 作为h-pgds抑制剂的喹啉-3-甲酰胺

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12435068B2 (en) 2018-10-24 2025-10-07 Elanco Animal Health Gmbh Anthelmintic compounds
US12312356B2 (en) 2020-05-29 2025-05-27 Boehringer Ingelheim Vetmedica Gmbh Anthelmintic heterocyclic compounds

Also Published As

Publication number Publication date
NZ752550A (en) 2023-03-31
US11505545B2 (en) 2022-11-22
PL3538512T3 (pl) 2021-11-22
MX2019005569A (es) 2019-09-05
MY196327A (en) 2023-03-24
EP3538512A1 (en) 2019-09-18
SG11201903059SA (en) 2019-05-30
IL266407A (en) 2019-06-30
EP3538512B1 (en) 2021-06-16
UA126119C2 (uk) 2022-08-17
CN109890793A (zh) 2019-06-14
TW201829384A (zh) 2018-08-16
WO2018087036A1 (en) 2018-05-17
CO2019004776A2 (es) 2019-07-31
SI3538512T1 (sl) 2021-09-30
AU2017357503A1 (en) 2019-05-02
UY37480A (es) 2018-06-29
JP7165129B2 (ja) 2022-11-02
CA3043298A1 (en) 2018-05-17
US20200024264A1 (en) 2020-01-23
BR112019009529A2 (pt) 2019-07-30
RU2019117917A3 (https=) 2021-03-05
DK3538512T3 (da) 2021-07-05
PT3538512T (pt) 2021-08-16
TWI821165B (zh) 2023-11-11
AU2017357503B2 (en) 2022-02-17
RU2019117917A (ru) 2020-12-11
PH12019501034A1 (en) 2019-12-02
JP2019535706A (ja) 2019-12-12
IL266407B (en) 2021-10-31
CN109890793B (zh) 2022-11-18
KR102595730B1 (ko) 2023-10-27
DOP2019000117A (es) 2019-05-31
ES2884073T3 (es) 2021-12-10
US10889573B2 (en) 2021-01-12
US20210115026A1 (en) 2021-04-22
ZA201903708B (en) 2022-11-30
KR20190076980A (ko) 2019-07-02

Similar Documents

Publication Publication Date Title
CL2019001292A1 (es) Nuevos derivados de quinolina.
CL2020000301A1 (es) Nuevos derivados de quinolina.
UY37789A (es) Nuevos derivados de azaquinolina
CO2019000386A2 (es) Compuestos heterocíclicos como inmunomoduladores
CL2019003078A1 (es) Nuevos derivados de pirazol bicíclicos.
CO2017001994A2 (es) Compuestos activos hacia bromodominios
CL2019000090A1 (es) 3-metil pirazinas 2,5-disustituidas y 3-metil pirazinas 2,5,6-trisustituidas como inhibidores alostéricos de shp2.
SV2018005787A (es) 3-oxo-2,6-difenil-2,3-dihidropiridazin-4-carboxamidas
UY37460A (es) 1,2,4-triazolonas con anelación en 4 y 5
MX384948B (es) Derivados de carbonucleósidos sustituidos útiles como agentes antineoplásicos.
MX2020011873A (es) Nuevos derivados de quinolina.
BR112017003054A2 (pt) compostos de aminopirimidinila como inibidores de jak
SV2016005257A (es) Benzimidazol-2-aminas como inhibidores de midh1
BR112018010720A2 (pt) agonistas do receptor de apelina e métodos de uso
UY36075A (es) Derivados de tubulisina
UY37832A (es) Dihidrooxadiazinonas
BR112016018062A8 (pt) compostos terapêuticos, composição farmacêutica e usos
NI202000031A (es) Novedosos derivados de pirazolo-pirrolo-pirimidina como inhibidores de p2x3
MX2019006893A (es) Inhibidores heterociclicos de mct4.
UY37250A (es) Derivados macrocíclicos de indol
UY37971A (es) Derivados de indol macrocíclicos sustituidos
EA201791454A1 (ru) Лекарственные формы для трансдермального введения
UY37973A (es) Derivados de indol macrocíclicos
MX2018005987A (es) Compuestos heterociclicos para el tratamiento de enfermedades.
EA202090732A1 (ru) Составы для трансдермального введения